Dose optimization of deuruxolitinib in adults with alopecia areata: A phase 2 randomized trial.
- DOI
- 10.1016/j.jaad.2026.09.013
- Published
- 2026 Sep 11
- Container
- Journal of the American Academy of Dermatology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.jaad.2026.09.013,
title = {Dose optimization of deuruxolitinib in adults with alopecia areata: A phase 2 randomized trial.},
author = {King B and Kempers S and Mesinkovska NA and Mirmirani P and McMichael A and Mackay-Wiggan J and Senna MM and Roberts JL and Mostaghimi A and Jarell A and Daly B and Hamilton C and Cassella J},
year = {2026},
journal = {Journal of the American Academy of Dermatology},
doi = {10.1016/j.jaad.2026.09.013},
url = {https://doi.org/10.1016/j.jaad.2026.09.013}
}RIS
TY - JOUR TI - Dose optimization of deuruxolitinib in adults with alopecia areata: A phase 2 randomized trial. AU - King B AU - Kempers S AU - Mesinkovska NA AU - Mirmirani P AU - McMichael A AU - Mackay-Wiggan J AU - Senna MM AU - Roberts JL AU - Mostaghimi A AU - Jarell A AU - Daly B AU - Hamilton C AU - Cassella J PY - 2026 JO - Journal of the American Academy of Dermatology DO - 10.1016/j.jaad.2026.09.013 UR - https://doi.org/10.1016/j.jaad.2026.09.013 ER -
APA
B, K., S, K., NA, M., P, M., A, M., J, M., MM, S., JL, R., A, M., A, J., B, D., C, H., & J, C. (2026). Dose optimization of deuruxolitinib in adults with alopecia areata: A phase 2 randomized trial.. Journal of the American Academy of Dermatology. https://doi.org/10.1016/j.jaad.2026.09.013
Source records
- pubmed · retrieved 2026-09-26T03:48:17.142Z